Ectin Research AB

NGM:ECTIN B Voorraadrapport

Marktkapitalisatie: SEK 355.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ectin Research Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Ectin Research has a total shareholder equity of SEK-74.0K and total debt of SEK730.0K, which brings its debt-to-equity ratio to -986.5%. Its total assets and total liabilities are SEK1.7M and SEK1.8M respectively.

Belangrijke informatie

-986.5%

Verhouding schuld/eigen vermogen

SEK 730.00k

Schuld

Rente dekkingsration/a
ContantSEK 1.15m
Aandelen-SEK 74.00k
Totaal verplichtingenSEK 1.78m
Totaal activaSEK 1.71m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: ECTIN B has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langlopende schulden: ECTIN B has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ECTIN B has negative shareholder equity, which is a more serious situation than a high debt level.

Schuld verminderen: ECTIN B's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: ECTIN B has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: ECTIN B has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.3% each year.


Ontdek gezonde bedrijven